In the wake of incidents where several children died in Madhya Pradesh after consuming contaminated cough syrup, the World Health Organization (WHO) has identified three cough syrups manufactured in India. The global health body has instructed authorities to immediately report if these syrups are found in their countries.

Coldref Syrup, recently implicated in child death cases, is one of the three contaminated syrups flagged by the WHO. Specific batches of Coldref from Sresan Pharmaceuticals, Respifresh TR from Rednex Pharmaceuticals, and Relief from Shape Pharma have been identified as hazardous by the global health organization. Redraft this to English. and give me ash tags and search tags after camas.Bata Women’s Stylish Ballerina Flats – Trendy, Comfortable

Tamil Nadu-based Sresan Pharmaceuticals, the manufacturer of Coldref cough syrup, has completely lost its production license following the controversy. Laboratory tests confirmed that diethylene glycol (DEG), a toxic chemical, was responsible for the deaths of at least 22 children in Madhya Pradesh.

Against the backdrop of the child deaths and actions against the Coldref manufacturers, the WHO questioned Indian authorities on whether this syrup had been exported to other countries. According to the Central Drugs Standard Control Organization (CDSCO), these syrups contained approximately 500 times the permissible limit of the toxic diethylene glycol. Google to Invest Up to $15 Billion in India’s Largest AI and Data Center Hub in Visakhapatnam

The CDSCO informed the WHO that children under five years old who died in Madhya Pradesh had consumed these syrups. The Indian health authority clarified that no contaminated medicines were exported from India. The United States has also confirmed that no toxic cough syrups were shipped to their country.